1. The Mevalonate Pathway, a Metabolic Target in Cancer Therapy
   Borja Guerra et al, 2021, Frontiers in Oncology CrossRef
2. Statins: Are Lipid-lowering Drugs Useful in Sarcomas?
   José M. García-Castellano et al, 2023, Bone Tumours - A Comprehensive Review of Selected Topics CrossRef
3. Effect of different solvents on nisin ZP potential as anticancer agent against MG-63 osteosarcoma cells
   Muhammad Fairuz Azmi et al, 2022, Asia Pacific Journal of Molecular Biology and Biotechnology CrossRef
4. Biomechanical Aspects in Bone Tumor Engineering
   Ksenia Menshikh et al, 2024, Tissue Engineering Part B: Reviews CrossRef
5. The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins
   Huanbiao Mo et al, 2019, Frontiers in Pharmacology CrossRef
6. Identifying squalene epoxidase as a metabolic vulnerability in high‐risk osteosarcoma using an artificial intelligence‐derived prognostic index
   Yongjie Wang et al, 2024, Clinical and Translational Medicine CrossRef
7. Porous Composite Granules with Potential Function of Bone Substitute and Simvastatin Releasing System: A Preliminary Study
   Aleksandra Laskus-Zakrzewska et al, 2021, Materials CrossRef
8. Alleviation of Simvastatin-Induced Myopathy in Rats by the Standardized Extract of Ginkgo Biloba (EGb761): Insights into the Mechanisms of Action
   Amany R. Mahmoud et al, 2019, Cells Tissues Organs CrossRef
9. Evaluation of geranylgeranyl diphosphate synthase inhibition as a novel strategy for the treatment of osteosarcoma and Ewing sarcoma
   Staci L. Haney et al, 2023, Drug Development Research CrossRef